Recruiting NA Psychomotor Disadaptation Syndrome

New treatment option for Psychomotor Disadaptation Syndrome

Official title The Benefits of Virtual Reality in the Care of Elderly People With Psychomotor Disadaptation Syndrome

ClinicalTrials.gov ID: NCT07026890

What this study is testing

What it's testing
Psychomotor Disadaptation Syndrome (PMDS) is characterised by a deterioration in postural function, gait and psychomotor automatisms in the elderly. It is often associated with falls and can manifest itself as retropulsion, gait abnormalities, neurological disorders and psycho-behavioural problems.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 65 and older

You may be able to join if

  • Person who has given written consent
  • Person aged ≥ 65 years;
  • With a proven diagnosis of motor maladjustment syndrome;
  • Hospitalised in a geriatric care unit;
  • Able to understand a simple instruction and answer a closed question;

You likely can't join if

  • Person not affiliated to or not benefiting from a social security scheme
  • Person subject to a legal protection measure (curatorship, guardianship)
  • Person subject to a judicial protection measure
  • An adult who is incapable or unable to give consent
  • Persons with epilepsy, kinetosis or known claustrophobia Persons unable to understand simple instructions for carrying out tests
  • Anyone with a severe visual and/or hearing impairment
See the full eligibility criteria
Who can join
  • Person who has given written consent
  • Person aged ≥ 65 years;
  • With a proven diagnosis of motor maladjustment syndrome;
  • Hospitalised in a geriatric care unit;
  • Able to understand a simple instruction and answer a closed question;
  • Ability to perform the TUG within 7 days of arriving on site
What rules you out
  • Person not affiliated to or not benefiting from a social security scheme
  • Person subject to a legal protection measure (curatorship, guardianship)
  • Person subject to a judicial protection measure
  • An adult who is incapable or unable to give consent
  • Persons with epilepsy, kinetosis or known claustrophobia Persons unable to understand simple instructions for carrying out tests
  • Anyone with a severe visual and/or hearing impairment
  • Any person with a behavioural disorder (agitation, aggressiveness)
  • Any person with a severe walking or balance problem that makes motor exercises unsuitable
  • Anyone with a pathology, injury, wound or severe deformity to the head or cervical spine
  • Any person suffering from severe vertigo, diagnosed at the discretion of the investigating doctor
  • Inability to use arm for pointing
  • Persons susceptible to migraines
  • Non-French speakers
  • Anyone with an inter-pupillary distance outside the range of possible helmet adjustments

The study team makes the final eligibility decision.

Where it's taking place

  • Dijon, France

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 65 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Dijon, France. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.